PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1238739
PUBLISHER: Arizton Advisory & Intelligence | PRODUCT CODE: 1238739
Transport Media Market - Global Outlook & Forecast 2023-2028
The global transport media market was valued at USD 13.15 billion in 2022 and is expected to reach USD 12.59 billion by 2028
MARKET DRIVERS & OPPORTUNITIES
Technological Advancement in Transport Media
During the COVID-19 pandemic, several advancements and new products have been launched in the transport media market. For several decades several transport media solutions have been introduced in the market to stabilize the specimen for the detection of microbial presence during the diagnostic investigation. From 2019 to 2022, some of the new products launched by various vendors were based on the high demand for diagnosing SARS-COV-2 viral infection. In addition, the development of formulations and advanced designs for appropriate sample collection increased the adoption of transport media and delivered lucrative market growth opportunities. In addition, the emerging monkeypox infectious disease is expected to drive the transport media market.
Several infectious disease outbreaks have significantly improved transport media solutions in recent years. Several new products are introduced with advanced and unique technologies to ease in detection and diagnosis of infected patients. Thermo Fisher Scientific designed a fully innovative non-hazardous virus inactivation medium that supports the safe collection and transport of the COVID-19 virus. In 2021, VIRCELL S.L. launched a new transport medium solution for pediatric clinical diagnostics for collecting and preserving various viruses. In addition, the increased funding for infectious diseases diagnosis and growing research towards viral transport media due to the COVID-19 pandemic deliver lucrative opportunities for transport media market growth.
Impact of COVID-19
The COVID-19 pandemic positively increased awareness about diagnosis and transport media relations among medical professionals and people, which drove the high demand for transport media. Also, the increasing production capacity of transport media solutions increases the high capacity of manufacturers. Most leading and emerging market players expand their manufacturing units with advanced facilities, expected to drive transport media market growth.
Increasing Prevalence of Infectious Diseases
In 2019, the viral infection SARS-COV-2 started to spread worldwide, and millions of people got infected as of November 2022. With the increasing prevalence of infectious diseases worldwide, the demand for transport media increased in detecting and diagnosing viral and non-viral infectious diseases. The emerging and re-emerging infectious diseases impacting human life cause millions of deaths annually. The growing burden of infectious diseases continuously increases the demand for transport media solutions and boosts market growth. The increasing diagnosis rate for infectious diseases is accelerating the transport media industry's growth. Globally, billions of lives are attributed to infectious diseases. The increasing awareness, rising healthcare expenditure, and growing access to health services resulted in the high demand for infectious disease cures, propelling the market growth.
SEGMENTATION INSIGHTS
INSIGHTS BY PRODUCT
The global transport media market by product is segmented into viral transport media, universal transport media, molecular transport media, and others. The other transport media segments included Cary & Blair medium, Amies medium, Stuarts medium, alkaline peptone water, and buffered glycerol saline. In 2022, the viral transport media segment accounted for a 55.75% higher industry share and dominated the other segments. The factors that increase the high revenue of viral transport media are the significant patient population infected with viral infectious diseases, significant diagnosis and testing done for COVID-19, and increasing awareness for diagnosis and pre-clinical diagnosis and testing. These factors significantly improved the viral transport media application rate and accelerated segmental growth. In the UK, the government has published and implemented guidelines to test monkeypox specimen samples and sample transporting through viral transport media.
Segmentation by Product
- Viral Transport Media
- Universal Transport Media
- Molecular Transport Media
INSIGHTS BY APPLICATION
The global transport media market by application is segmented into diagnosis and pre-clinical testing. The diagnosis segment accounted for a 65.75% higher market share in 2022 and dominated the application segment. Due to the increasing infectious diseases prevalence and the emergence of COVID-19, monkeypox, and influenza virus infection in developed and developing countries, the demand for diagnosis is increased, which resulted in high segmental growth. In developed regions such as North America and Europe, the pre-clinical testing rate is higher than in developing regions such as APAC, Latin America, & Middle East & Africa. North America and Europe are showing steady growth for pre-clinical testing and driving segmental growth.
Segmentation by Application
- Diagnosis
- Pre-clinical Testing
INSIGHTS BY INDICATION
The viral diseases indication segment dominated the global transport media in 2022 and was valued at USD 9.74 million. The prevalence of viral infectious diseases such as influenza virus, herpes simplex virus, varicella zoster, respiratory syncytial virus, and other emerging such as monkeypox and already emerged COVID-19 infectious diseases drive high segmental growth. Moreover, COVID-19 and influenza are both contagious respiratory illnesses caused by different types of viruses, such as COVID-19 is caused by SARS-COV-2, and the influenza virus causes flu. Influenza and COVID-19 are considered severe public health concerns worldwide, impacting millions of lives. Since 2020, across the world, various public health and social measures have been implemented to mitigate the COVID-19 pandemic caused by SARS-COV-2. In 2022, the viral diseases segment accounted for a 74.05% market share in the global transport media market.
Segmentation by Indication
- Viral Diseases
- Non-Viral Diseases
INSIGHTS BY END-USER
The diagnostics labs became a major health service from 2020 to 2022 due to COVID-19 and other infectious disease detection. Due to the increased demand for diagnosis and testing in the COVID-19 pandemic, diagnostic labs have become a major part of diagnosis and accounted for a higher transport media market share in 2022. The high number of COVID-19 detection tests and emerging demand for monkeypox and influenza virus burden in 2022 are accelerating the segmental growth. In addition, other infectious diseases constantly demanded early detection and diagnosis to boost segmental growth. However, the diagnostic lab's segment growth is expected to decrease with the decreasing demand for COVID-19 diagnosis. And the hospitals and clinics segment is expected to increase with a substantial growth rate during the forecast period. In 2022, the diagnostic lab segment accounted for 41.52% market share in the global transport media market.
Segmentation by End-users
- Diagnostic Labs
- Hospitals & Clinics
- Others
GEOGRAPHICAL ANALYSIS
North America dominated the transport media market and accounted for a 33.02% share in 2022. The increasing prevalence of viral infectious diseases and associated population, high diagnostic and pre-clinical testing rate, and increasing focus on research and development in the region on viral diseases boost the regional industry growth. The region's higher prevalence of infectious diseases continuously accelerates the diagnosis and testing demand, leading to an increased high requirement for transport media solutions. North America was one of the major regions affected by the SARS-COV-2 infection and delivered higher market growth by transport media solutions.
Segmentation by Geography
- North America
- US
- Canada
- Europe
- UK
- Italy
- France
- Spain
- Germany
- APAC
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- Turkey
VENDOR LANDSCAPE
The leading global transport media market players include BD, Puritan Medical, Thermo Fisher Scientific, Laboratory Corporation of America Holdings, Hardy Diagnostics, HiMedia Laboratories, and Vircell. The global industry is highly competitive, with local, domestic, regional, and global players worldwide. The market player's geographical presence and broad distribution channels make the market competitive through major supply, import, and export strategies. During the COVID-19 pandemic, the significantly increased demand for transport media drove high export and import in different countries through various market players.
Key Company Profiles
- BD
- Hardy Diagnostics
- HiMedia Laboratories
- Laboratory Corporation of America
- Puritan Medica Products
- Thermo Fisher Scientific
- Vircell
Other Prominent Vendors
- AB Medical
- Alpha-Tec Systems
- AccuGene USA
- Apical Scientific
- Azooka Labs
- Biomed Diagnostics
- bioBoaVista
- BioGenex
- BIOLOGIX Group
- BIOCOMMA
- Charm Sciences
- Creative Life Sciences
- Citotest Labware Manufacturing
- CPT Medical
- COPAN Diagnostics
- DiaSorin Molecular
- EKF Diagnostics Holding
- Ensol Biosciences
- General Biologics
- Gentueri
- Han Chang Medic
- Hebei Chaoran Medical Instruments
- Innolyzer Labs
- KSL Diagnostics
- Lucence Health
- LaunchWorks
- Liofilchem
- Medical Wire & Equipment
- Miraclean Technology
- MetaDesign Solutions
- Quidel Corporation
- Trinity Biotech
- Manila HealthTek
- MATTEK
- Nodford International
- Starplex Scientific
- Sansure Biotech
- Sisco Research Laboratories
- Teknova
- Titan Biotech
- Vegas Biotech
- Yocon Biology Technology Company
- Zybio
KEY QUESTIONS ANSWERED
- 1. How big is the transport media market?
- 2. What is the projected CAGR of the transport media market during the forecast period?
- 3. Who are the key players in the global transport media market?
- 4. What are the growing trends in the transport media market?
- 5. Which region holds the most significant global transport media market share?
TABLE OF CONTENTS
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
- 4.1 MARKET DEFINITION
- 4.1.1 INCLUSIONS
- 4.1.2 EXCLUSIONS
- 4.1.3 MARKET ESTIMATION CAVEATS
- 4.2 BASE YEAR
- 4.3 SCOPE OF THE STUDY
- 4.3.1 MARKET BY PRODUCT SEGMENT
- 4.3.2 MARKET BY APPLICATION SEGMENT
- 4.3.3 MARKET BY INDICATION SEGMENT
- 4.3.4 MARKET BY END-USERS
- 4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
- 5.1 KEY CAVEATS
- 5.2 CURRENCY CONVERSION
- 5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
- 6.1 OVERVIEW
7 MARKET AT A GLANCE
8 INTRODUCTION
- 8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
- 9.1 NEW PRODUCT LAUNCHED FOR TRANSPORT MEDIA
- 9.2 TECHNOLOGICAL ADVANCES IN TRANSPORT MEDIA
- 9.3 RAPID ACCELERATION OF DIAGNOSTICS AND FUNDING DURING PANDEMIC
- 9.4 INCREASING RESEARCH AND FOCUS ON VIRAL TRANSPORT MEDIA
10 MARKET GROWTH ENABLERS
- 10.1 IMPACTS OF COVID-19
- 10.2 INCREASING PREVALENCE OF INFECTIOUS DISEASES
- 10.3 INCREASING DIAGNOSIS RATE FOR INFECTIOUS DISEASES
11 MARKET RESTRAINTS
- 11.1 AVAILABLE ALTERNATIVE SOLUTIONS FOR TRANSPORT MEDIA
- 11.2 LIMITED ACCESS TO DIAGNOSTIC SERVICES IN LMICS
- 11.3 CHALLENGES ASSOCIATED WITH TRANSPORT MEDIA
12 MARKET LANDSCAPE
- 12.1 MARKET OVERVIEW
- 12.2 MARKET SIZE & FORECAST
- 12.2.1 INSIGHTS BY PRODUCT
- 12.2.2 INSIGHTS BY APPLICATION
- 12.2.3 INSIGHTS BY INDICATION
- 12.2.4 INSIGHTS BY END-USERS
- 12.2.5 INSIGHTS BY GEOGRAPHY
- 12.3 FIVE FORCES ANALYSIS
- 12.3.1 THREAT OF NEW ENTRANTS
- 12.3.2 BARGAINING POWER OF SUPPLIERS
- 12.3.3 BARGAINING POWER OF BUYERS
- 12.3.4 THREAT OF SUBSTITUTES
- 12.3.5 COMPETITIVE RIVALRY
13 PRODUCT
- 13.1 MARKET SNAPSHOT & GROWTH ENGINE
- 13.2 MARKET OVERVIEW
- 13.3 VIRAL TRANSPORT MEDIA (VTM)
- 13.3.1 MARKET OVERVIEW
- 13.3.2 MARKET SIZE & FORECAST
- 13.3.3 MARKET BY GEOGRAPHY
- 13.4 UNIVERSAL TRANSPORT MEDIA (UTM)
- 13.4.1 MARKET OVERVIEW
- 13.4.2 MARKET SIZE & FORECAST
- 13.4.3 MARKET BY GEOGRAPHY
- 13.5 MOLECULAR TRANSPORT MEDIA (MTM)
- 13.5.1 MARKET OVERVIEW
- 13.5.2 MARKET SIZE & FORECAST
- 13.5.3 MARKET BY GEOGRAPHY
- 13.6 OTHERS
- 13.6.1 MARKET OVERVIEW
- 13.6.2 MARKET SIZE & FORECAST
- 13.6.3 MARKET BY GEOGRAPHY
14 APPLICATION
- 14.1 MARKET SNAPSHOT & GROWTH ENGINE
- 14.2 MARKET OVERVIEW
- 14.3 DIAGNOSIS
- 14.3.1 MARKET OVERVIEW
- 14.3.2 MARKET SIZE & FORECAST
- 14.3.3 MARKET BY GEOGRAPHY
- 14.4 PRECLINICAL TESTINGS
- 14.4.1 MARKET OVERVIEW
- 14.4.2 MARKET SIZE & FORECAST
- 14.4.3 MARKET BY GEOGRAPHY
15 INDICATION
- 15.1 MARKET SNAPSHOT & GROWTH ENGINE
- 15.2 MARKET OVERVIEW
- 15.3 VIRAL DISEASES
- 15.3.1 MARKET OVERVIEW
- 15.3.2 MARKET SIZE & FORECAST
- 15.3.3 MARKET BY GEOGRAPHY
- 15.4 NON-VIRAL DISEASE
- 15.4.1 MARKET OVERVIEW
- 15.4.2 MARKET SIZE & FORECAST
- 15.4.3 MARKET BY GEOGRAPHY
16 END-USERS
- 16.1 MARKET SNAPSHOT & GROWTH ENGINE
- 16.2 MARKET OVERVIEW
- 16.3 DIAGNOSTIC LABS
- 16.3.1 MARKET OVERVIEW
- 16.3.2 MARKET SIZE & FORECAST
- 16.3.3 MARKET BY GEOGRAPHY
- 16.4 HOSPITALS AND CLINICS
- 16.4.1 MARKET OVERVIEW
- 16.4.2 MARKET SIZE & FORECAST
- 16.4.3 MARKET BY GEOGRAPHY
- 16.5 OTHERS
- 16.5.1 MARKET OVERVIEW
- 16.5.2 MARKET SIZE & FORECAST
- 16.5.3 MARKET BY GEOGRAPHY
17 GEOGRAPHY
- 17.1 MARKET SNAPSHOT & GROWTH ENGINE
- 17.2 GEOGRAPHIC OVERVIEW
18 NORTH AMERICA
- 18.1 MARKET OVERVIEW
- 18.2 MARKET SIZE & FORECAST
- 18.3 PRODUCT
- 18.3.1 MARKET SIZE & FORECAST
- 18.4 APPLICATION
- 18.4.1 MARKET SIZE & FORECAST
- 18.5 INDICATION
- 18.5.1 MARKET SIZE & FORECAST
- 18.6 END-USERS
- 18.6.1 MARKET SIZE & FORECAST
- 18.7 KEY COUNTRIES
- 18.7.1 US: MARKET SIZE & FORECAST
- 18.7.2 CANADA: MARKET SIZE & FORECAST
19 EUROPE
- 19.1 MARKET OVERVIEW
- 19.2 MARKET SIZE & FORECAST
- 19.3 PRODUCT
- 19.3.1 MARKET SIZE & FORECAST
- 19.4 APPLICATION
- 19.4.1 MARKET SIZE & FORECAST
- 19.5 INDICATION
- 19.5.1 MARKET SIZE & FORECAST
- 19.6 END-USERS
- 19.6.1 MARKET SIZE & FORECAST
- 19.7 KEY COUNTRIES
- 19.7.1 UK: MARKET SIZE & FORECAST
- 19.7.2 ITALY: MARKET SIZE & FORECAST
- 19.7.3 FRANCE: MARKET SIZE & FORECAST
- 19.7.4 GERMANY: MARKET SIZE & FORECAST
- 19.7.5 SPAIN: MARKET SIZE & FORECAST
20 APAC
- 20.1 MARKET OVERVIEW
- 20.2 MARKET SIZE & FORECAST
- 20.3 PRODUCT
- 20.3.1 MARKET SIZE & FORECAST
- 20.4 APPLICATION
- 20.4.1 MARKET SIZE & FORECAST
- 20.5 INDICATION
- 20.5.1 MARKET SIZE & FORECAST
- 20.6 END-USERS
- 20.6.1 MARKET SIZE & FORECAST
- 20.7 KEY COUNTRIES
- 20.7.1 CHINA: MARKET SIZE & FORECAST
- 20.7.2 JAPAN: MARKET SIZE & FORECAST
- 20.7.3 INDIA: MARKET SIZE & FORECAST
- 20.7.4 AUSTRALIA: MARKET SIZE & FORECAST
- 20.7.5 SOUTH KOREA: MARKET SIZE & FORECAST
21 LATIN AMERICA
- 21.1 MARKET OVERVIEW
- 21.2 MARKET SIZE & FORECAST
- 21.3 PRODUCT
- 21.3.1 MARKET SIZE & FORECAST
- 21.4 APPLICATION
- 21.4.1 MARKET SIZE & FORECAST
- 21.5 INDICATION
- 21.5.1 MARKET SIZE & FORECAST
- 21.6 END-USERS
- 21.6.1 MARKET SIZE & FORECAST
- 21.7 KEY COUNTRIES
- 21.7.1 BRAZIL: MARKET SIZE & FORECAST
- 21.7.2 MEXICO: MARKET SIZE & FORECAST
- 21.7.3 ARGENTINA: MARKET SIZE & FORECAST
22 MIDDLE EAST AFRICA
- 22.1 MARKET OVERVIEW
- 22.2 MARKET SIZE & FORECAST
- 22.3 PRODUCT
- 22.3.1 MARKET SIZE & FORECAST
- 22.4 APPLICATION
- 22.4.1 MARKET SIZE & FORECAST
- 22.5 INDICATION
- 22.5.1 MARKET SIZE & FORECAST
- 22.6 END-USERS
- 22.6.1 MARKET SIZE & FORECAST
- 22.7 KEY COUNTRIES
- 22.7.1 TURKEY: MARKET SIZE & FORECAST
- 22.7.2 SAUDI ARABIA: MARKET SIZE & FORECAST
- 22.7.3 SOUTH AFRICA: MARKET SIZE & FORECAST
23 COMPETITIVE LANDSCAPE
- 23.1 COMPETITION OVERVIEW
- 23.2 MARKET SHARE ANALYSIS
- 23.2.1 BD
- 23.2.2 HARDY DIAGNOSTICS
- 23.2.3 HIMEDIA LABORATORIES
- 23.2.4 LABORATORY CORPORATION OF AMERICA
- 23.2.5 PURITAN MEDICAL PRODUCTS
- 23.2.6 THERMO FISHER SCIENTIFIC
- 23.2.7 VIRCELL
24 KEY COMPANY PROFILES
- 24.1 BD
- 24.1.1 BUSINESS OVERVIEW
- 24.1.2 PRODUCT OFFERINGS
- 24.1.3 KEY STRATEGIES
- 24.1.4 KEY STRENGTHS
- 24.1.5 KEY OPPORTUNITIES
- 24.2 HARDY DIAGNOSTICS
- 24.2.1 BUSINESS OVERVIEW
- 24.2.2 PRODUCT OFFERINGS
- 24.2.3 KEY STRATEGIES
- 24.2.4 KEY STRENGTHS
- 24.2.5 KEY OPPORTUNITIES
- 24.3 HIMEDIA LABORATORIES
- 24.3.1 BUSINESS OVERVIEW
- 24.3.2 PRODUCT OFFERINGS
- 24.3.3 KEY STRATEGIES
- 24.3.4 KEY STRENGTHS
- 24.3.5 KEY OPPORTUNITIES
- 24.4 LABORATORY CORPORATION OF AMERICA
- 24.4.1 BUSINESS OVERVIEW
- 24.4.2 PRODUCT OFFERINGS
- 24.4.3 KEY STRATEGIES
- 24.4.4 KEY STRENGTHS
- 24.4.5 KEY OPPORTUNITIES
- 24.5 PURITAN MEDICAL PRODUCTS
- 24.5.1 BUSINESS OVERVIEW
- 24.5.2 PRODUCT OFFERINGS
- 24.5.3 KEY STRATEGIES
- 24.5.4 KEY STRENGTHS
- 24.5.5 KEY OPPORTUNITIES
- 24.6 THERMO FISHER SCIENTIFIC
- 24.6.1 BUSINESS OVERVIEW
- 24.6.2 THERMO FISHER SCIENTIFIC IN TRANSPORT MEDIA MARKET
- 24.6.3 PRODUCT OFFERINGS
- 24.6.4 KEY STRATEGIES
- 24.6.5 KEY STRENGTHS
- 24.6.6 KEY OPPORTUNITIES
- 24.7 VIRCELL
- 24.7.1 BUSINESS OVERVIEW
- 24.7.2 PRODUCT OFFERINGS
- 24.7.3 KEY STRATEGIES
- 24.7.4 KEY STRENGTHS
- 24.7.5 KEY OPPORTUNITIES
25 OTHER PROMINENT VENDORS
- 25.1 AB MEDICAL
- 25.1.1 BUSINESS OVERVIEW
- 25.1.2 PRODUCT OFFERINGS
- 25.2 ALPHA-TEC SYSTEMS
- 25.2.1 BUSINESS OVERVIEW
- 25.2.2 PRODUCT OFFERINGS
- 25.3 ACCUGENE USA
- 25.3.1 BUSINESS OVERVIEW
- 25.3.2 PRODUCT OFFERINGS
- 25.4 APICAL SCIENTIFIC
- 25.4.1 BUSINESS OVERVIEW
- 25.4.2 PRODUCT OFFERINGS
- 25.5 AZOOKA LABS
- 25.5.1 BUSINESS OVERVIEW
- 25.5.2 PRODUCT OFFERINGS
- 25.6 BIOMED DIAGNOSTICS
- 25.6.1 BUSINESS OVERVIEW
- 25.6.2 PRODUCT OFFERINGS
- 25.7 BIOBOAVISTA
- 25.7.1 BUSINESS OVERVIEW
- 25.7.2 PRODUCT OFFERINGS
- 25.8 BIOGENEX
- 25.8.1 BUSINESS OVERVIEW
- 25.8.2 PRODUCT OFFERINGS
- 25.9 BIOLOGIX GROUP
- 25.9.1 BUSINESS OVERVIEW
- 25.9.2 PRODUCT OFFERINGS
- 25.10 BIOCOMMA
- 25.10.1 BUSINESS OVERVIEW
- 25.10.2 PRODUCT OFFERINGS
- 25.11 CHARM SCIENCES
- 25.11.1 BUSINESS OVERVIEW
- 25.11.2 PRODUCT OFFERINGS
- 25.12 CREATIVE LIFE SCIENCES CO., LTD.
- 25.12.1 BUSINESS OVERVIEW
- 25.12.2 PRODUCT OFFERINGS
- 25.13 CITOTEST LABWARE MANUFACTURING
- 25.13.1 BUSINESS OVERVIEW
- 25.13.2 PRODUCT OFFERINGS
- 25.14 CPT MEDICAL
- 25.14.1 BUSINESS OVERVIEW
- 25.14.2 PRODUCT OFFERINGS
- 25.15 COPAN DIAGNOSTICS
- 25.15.1 BUSINESS OVERVIEW
- 25.15.2 PRODUCT OFFERINGS
- 25.16 DIASORIN MOLECULAR
- 25.16.1 BUSINESS OVERVIEW
- 25.16.2 PRODUCT OFFERINGS
- 25.17 EFK DIAGNOSTICS HOLDING
- 25.17.1 BUSINESS OVERVIEW
- 25.17.2 PRODUCT OFFERINGS
- 25.18 ENSOL BIOSCIENCES
- 25.18.1 BUSINESS OVERVIEW
- 25.18.2 PRODUCT OFFERINGS
- 25.19 GENERAL BIOLOGICS
- 25.19.1 BUSINESS OVERVIEW
- 25.19.2 PRODUCT OFFERINGS
- 25.20 GENTUERI
- 25.20.1 BUSINESS OVERVIEW
- 25.20.2 PRODUCT OFFERINGS
- 25.21 HANG CHANG MEDIC
- 25.21.1 BUSINESS OVERVIEW
- 25.21.2 PRODUCT OFFERINGS
- 25.22 HEBEI CHAORAN MEDICAL INSTRUMENTS
- 25.22.1 BUSINESS OVERVIEW
- 25.22.2 PRODUCT OFFERINGS
- 25.23 INNOLYZER LABS
- 25.23.1 BUSINESS OVERVIEW
- 25.23.2 PRODUCT OFFERINGS
- 25.24 KSL DIAGNOSTICS
- 25.24.1 BUSINESS OVERVIEW
- 25.24.2 PRODUCT OFFERINGS
- 25.25 LUCENCE HEALTH
- 25.25.1 BUSINESS OVERVIEW
- 25.25.2 PRODUCT OFFERINGS
- 25.26 LAUNCHWORKS
- 25.26.1 BUSINESS OVERVIEW
- 25.26.2 PRODUCT OFFERINGS
- 25.27 LIOFILCHEM
- 25.27.1 BUSINESS OVERVIEW
- 25.27.2 PRODUCT OFFERINGS
- 25.28 MEDICAL WIRE & EQUIPMENT
- 25.28.1 BUSINESS OVERVIEW
- 25.28.2 PRODUCT OFFERINGS
- 25.29 MIRACLEAN TECHNOLOGY
- 25.29.1 BUSINESS OVERVIEW
- 25.29.2 PRODUCT OFFERINGS
- 25.30 METADESIGN SOLUTIONS
- 25.30.1 BUSINESS OVERVIEW
- 25.30.2 PRODUCT OFFERINGS
- 25.31 QUIDEL CORPORATION
- 25.31.1 BUSINESS OVERVIEW
- 25.31.2 PRODUCT OFFERINGS
- 25.32 TRINITY BIOTECH
- 25.32.1 BUSINESS OVERVIEW
- 25.32.2 PRODUCT OFFERINGS
- 25.33 MANILA HEALTHTEK
- 25.33.1 BUSINESS OVERVIEW
- 25.33.2 PRODUCT OFFERINGS
- 25.34 MATTEK
- 25.34.1 BUSINESS OVERVIEW
- 25.34.2 PRODUCT OFFERINGS
- 25.35 NODFORD INTERNATIONAL
- 25.35.1 BUSINESS OVERVIEW
- 25.35.2 PRODUCT OFFERINGS
- 25.36 STARPLEX SCIENTIFIC
- 25.36.1 BUSINESS OVERVIEW
- 25.36.2 PRODUCT OFFERINGS
- 25.37 SANSURE BIOTECH
- 25.37.1 BUSINESS OVERVIEW
- 25.37.2 PRODUCT OFFERINGS
- 25.38 SISCO RESEARCH LABORATORIES
- 25.38.1 BUSINESS OVERVIEW
- 25.38.2 PRODUCT OFFERINGS
- 25.39 TEKNOVA
- 25.39.1 BUSINESS OVERVIEW
- 25.39.2 PRODUCT OFFERINGS
- 25.40 TITAN BIOTECH
- 25.40.1 BUSINESS OVERVIEW
- 25.40.2 PRODUCT OFFERINGS
- 25.41 VEGAS BIOTECH
- 25.41.1 BUSINESS OVERVIEW
- 25.41.2 PRODUCT OFFERINGS
- 25.42 YOCON BIOLOGY TECHNOLOGY COMPANY
- 25.42.1 BUSINESS OVERVIEW
- 25.42.2 PRODUCT OFFERINGS
- 25.43 ZYBIO
- 25.43.1 BUSINESS OVERVIEW
- 25.43.2 PRODUCT OFFERINGS
26 REPORT SUMMARY
- 26.1 KEY TAKEAWAYS
- 26.2 STRATEGIC RECOMMENDATIONS
27 QUANTITATIVE SUMMARY
- 27.1 MARKET BY GEOGRAPHY
- 27.2 MARKET BY PRODUCT
- 27.3 MARKET BY APPLICATION
- 27.4 MARKET BY INDICATION
- 27.5 MARKET BY END-USERS
- 27.6 PRODUCT: MARKET BY GEOGRAPHY
- 27.6.1 VIRAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY
- 27.6.2 UNIVERSAL TRANSPORT MEDIA: MARKET BY GEOGRAPHY
- 27.6.3 MOLECULAR TRANSPORT MEDIA: MARKET BY GEOGRAPHY
- 27.6.4 OTHER TRANSPORT MEDIA: MARKET BY GEOGRAPHY
- 27.7 APPLICATION: MARKET BY GEOGRAPHY
- 27.7.1 DIAGNOSIS: MARKET BY GEOGRAPHY
- 27.7.2 PRE-CLINICAL TESTING: MARKET BY GEOGRAPHY
- 27.8 INDICATION: MARKET BY GEOGRAPHY
- 27.8.1 VIRAL DISEASE: MARKET BY GEOGRAPHY
- 27.8.2 NON-VIRAL DISEASE: MARKET BY GEOGRAPHY
- 27.9 END-USERS: MARKET BY GEOGRAPHY
- 27.9.1 DIAGNOSTIC LABS: MARKET BY GEOGRAPHY
- 27.9.2 HOSPITALS & CLINICS: MARKET BY GEOGRAPHY
- 27.9.3 OTHER END-USERS: MARKET BY GEOGRAPHY
28 APPENDIX
- 28.1 ABBREVIATIONS
LIST OF EXHIBITS
- EXHIBIT 1 SEGMENTATION OF GLOBAL TRANSPORT MEDIA MARKET
- EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2022
- EXHIBIT 3 TYPES OF TRANSPORT MEDIA
- EXHIBIT 4 IMPACT OF NEW PRODUCT LAUNCHED FOR TRANSPORT MEDIA
- EXHIBIT 5 IMPACT OF TECHNOLOGICAL ADVANCES IN TRANSPORT MEDIA
- EXHIBIT 6 IMPACT OF RAPID ACCELERATION OF DIAGNOSTICS AND FUNDING DURING PANDEMIC
- EXHIBIT 7 IMPACT OF INCREASING RESEARCH & FOCUS ON VIRAL TRANSPORT MEDIA
- EXHIBIT 8 IMPACT OF IMPACTS OF COVID-19
- EXHIBIT 9 IMPACTS OF COVID-19 ON TRANSPORT MEDIA MARKET
- EXHIBIT 10 IMPACT OF INCREASING PREVALENCE OF INFECTIOUS DISEASES
- EXHIBIT 11 IMPACT OF INCREASING DIAGNOSIS RATE FOR INFECTIOUS DISEASES
- EXHIBIT 12 NON-VARIOLA ORTHOPOX/MONKEYPOX TESTING: VOLUME VS. CAPACITY
- EXHIBIT 13 TOTAL COVID-19 TEST BY COUNTRIES (2020-2022)
- EXHIBIT 14 NON-VARIOLA ORTHOPOX/ MONKEYPOX TESTING FROM PUBLIC AND SELECTED COMMERCIAL LABORATORIES (2022)
- EXHIBIT 15 IMPACT OF AVAILABLE ALTERNATIVE SOLUTIONS FOR TRANSPORT MEDIA
- EXHIBIT 16 IMPACT OF LIMITED ACCESS TO DIAGNOSTIC AND SERVICES IN LMICS
- EXHIBIT 17 DIAGNOSTIC GAP FOR SOME HEALTH CONDITIONS (DATA BASED ON 16 DIFFERENT COUNTRIES 2021)
- EXHIBIT 18 IMPACT OF CHALLENGES ASSOCIATED WITH TRANSPORT MEDIA
- EXHIBIT 19 GLOBAL TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 20 GLOBAL TRANSPORT MEDIA MARKET SHARE BY PRODUCT 2022 & 2028
- EXHIBIT 21 GLOBAL TRANSPORT MEDIA MARKET SHARE BY APPLICATION 2022 & 2028
- EXHIBIT 22 GLOBAL TRANSPORT MEDIA MARKET SHARE BY INDICATION 2022 & 2028
- EXHIBIT 23 GLOBAL TRANSPORT MEDIA MARKET SHARE BY END-USERS 2022 & 2028
- EXHIBIT 24 GLOBAL TRANSPORT MEDIA MARKET SHARE BY GEOGRAPHY 2022 & 2028
- EXHIBIT 25 FIVE FORCES ANALYSIS 2022
- EXHIBIT 26 INCREMENTAL GROWTH BY PRODUCT 2022 & 2028
- EXHIBIT 27 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT (2022-2028)
- EXHIBIT 28 TRANSPORT MEDIA MARKET BY PRODUCT: INCREMENTAL GROWTH
- EXHIBIT 29 TRANSPORT MEDIA MARKET BY PRODUCT: ABSOLUTE GROWTH
- EXHIBIT 30 APPLICATION OF VIRAL TRANSPORT MEDIA
- EXHIBIT 31 VIRAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 32 GLOBAL VIRAL TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 33 ADVANTAGES DELIVERED BY SUBJECT UNIVERSAL TRANSPORT MEDIUM INCLUDES
- EXHIBIT 34 UNIVERSAL TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 35 GLOBAL UNIVERSAL TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 36 MOLECULAR TRANSPORT MEDIA ADVANTAGES & CAPABILITIES
- EXHIBIT 37 MOLECULAR TRANSPORT MEDIA THAT INACTIVATES MICROBES AND VIRUSES
- EXHIBIT 38 MOLECULAR TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 39 GLOBAL MOLECULAR TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 40 OTHERS TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 41 GLOBAL OTHERS TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 42 INCREMENTAL GROWTH BY APPLICATION 2022 & 2028
- EXHIBIT 43 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028
- EXHIBIT 44 TRANSPORT MEDIA MARKET BY APPLICATION: INCREMENTAL GROWTH
- EXHIBIT 45 TRANSPORT MEDIA MARKET BY APPLICATION: ABSOLUTE GROWTH
- EXHIBIT 46 TRANSPORT MEDIA MARKET BY DIAGNOSIS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 47 GLOBAL TRANSPORT MEDIA MARKET BY DIAGNOSIS 2022-2028 ($ MILLION)
- EXHIBIT 48 TRANSPORT MEDIA MARKET BY PRE-CLINICAL TESTING: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 49 GLOBAL TRANSPORT MEDIA MARKET BY PRE-CLINICAL TESTING 2022-2028 ($ MILLION)
- EXHIBIT 50 INCREMENTAL GROWTH BY INDICATION 2022 & 2028
- EXHIBIT 51 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022-2028
- EXHIBIT 52 TRANSPORT MEDIA MARKET BY INDICATION: INCREMENTAL GROWTH
- EXHIBIT 53 TRANSPORT MEDIA MARKET BY INDICATION: ABSOLUTE GROWTH
- EXHIBIT 54 IMPACT OF COVID-19 POSITIVITY ON INFLUENZA CASES GLOBALLY (2022)
- EXHIBIT 55 GLOBAL COVID-19 DAILY CASES (2022)
- EXHIBIT 56 TRANSPORT MEDIA MARKET BY VIRAL DISEASE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 57 GLOBAL TRANSPORT MEDIA MARKET BY VIRAL DISEASE 2022-2028 ($ MILLION)
- EXHIBIT 58 NON-VIRAL DISEASES THAT SUGGEST COLLECT THROUGH TRANSPORT MEDIA
- EXHIBIT 59 TRANSPORT MEDIA MARKET BY NON-VIRAL DISEASE: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 60 GLOBAL TRANSPORT MEDIA MARKET BY NON-VIRAL DISEASE 2022-2028 ($ MILLION)
- EXHIBIT 61 INCREMENTAL GROWTH BY END-USERS 2022 & 2028
- EXHIBIT 62 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022-2028
- EXHIBIT 63 TRANSPORT MEDIA MARKET BY END-USERS: INCREMENTAL GROWTH
- EXHIBIT 64 TRANSPORT MEDIA MARKET BY END-USERS: ABSOLUTE GROWTH
- EXHIBIT 65 TRANSPORT MEDIA MARKET BY DIAGNOSTIC LABS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 66 GLOBAL TRANSPORT MEDIA MARKET BY DIAGNOSTIC LABS 2022-2028 ($ MILLION)
- EXHIBIT 67 NUMBER OF COVID-19 PATIENTS IN HOSPITALS JAN-2022 TO OCT-2022
- EXHIBIT 68 TRANSPORT MEDIA MARKET BY HOSPITALS & CLINICS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 69 GLOBAL TRANSPORT MEDIA MARKET BY HOSPITALS & CLINICS 2022-2028 ($ MILLION)
- EXHIBIT 70 TRANSPORT MEDIA MARKET BY OTHER END-USERS: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 71 GLOBAL TRANSPORT MEDIA MARKET BY OTHER END-USERS 2022-2028 ($ MILLION)
- EXHIBIT 72 INCREMENTAL GROWTH BY GEOGRAPHY 2022 & 2028
- EXHIBIT 73 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY (2022-2028)
- EXHIBIT 74 TRANSPORT MEDIA MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
- EXHIBIT 75 TRANSPORT MEDIA MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
- EXHIBIT 76 NORTH AMERICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
- EXHIBIT 77 NORTH AMERICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 78 TRANSPORT MEDIA MARKET IN NORTH AMERICA 2022-2028 ($ MILLION)
- EXHIBIT 79 INCREMENTAL GROWTH IN NORTH AMERICA 2022 & 2028
- EXHIBIT 80 VIRAL INFECTIOUS DISEASES PREVALENCE IN US
- EXHIBIT 81 NUMBER OF LABS BY TYPE AND TEST VOLUME IN US (2015-2016)
- EXHIBIT 82 US TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 83 CANADA: TOTAL COVID-19 CASES IN 2022 (FROM 2020-2022)
- EXHIBIT 84 CANADA COVID-19 TEST PER 1,000 PEOPLE
- EXHIBIT 85 TRANSPORT MEDIA MARKET IN CANADA 2022-2028 ($ MILLION)
- EXHIBIT 86 EUROPE TRANSPORT MEDIA MARKET: KEY COUNTRIES
- EXHIBIT 87 EUROPE TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 88 TRANSPORT MEDIA MARKET IN EUROPE 2022-2028 ($ MILLION)
- EXHIBIT 89 INCREMENTAL GROWTH IN EUROPE 2022 & 2028
- EXHIBIT 90 FACTS ABOUT PATHOLOGY LABS IN ENGLAND (2022)
- EXHIBIT 91 IMPORT OF VIRAL TRANSPORT MEDIA FROM US, BELGIUM, AND FROM OTHER COUNTRIES IN UK IN 2022 ($ MILLION)
- EXHIBIT 92 UK TRANSPORT MEDIA MARKET 2022-2028 ($ MILLION)
- EXHIBIT 93 TRANSPORT MEDIA MARKET IN ITALY 2022-2028 ($ MILLION)
- EXHIBIT 94 TOTAL EXPENDITURE ON LABORATORY ANALYSIS IN FRANCE ($ BN) 2014 TO 2019
- EXHIBIT 95 FRANCE DAILY NEW COVID-19 CASES IN 2022 (CASES CONSIDERED ON 5TH DAY OF MONTH)
- EXHIBIT 96 TRANSPORT MEDIA MARKET IN FRANCE 2022-2028 ($ MILLION)
- EXHIBIT 97 GERMANY: DAILY COUNT OF COVID-19 CASES (15TH DAY OF MONTH)
- EXHIBIT 98 DAILY COVID-19 TESTS DONE PER THOUSAND PEOPLE IN GERMANY FROM JAN 2022 TO JUN-2022
- EXHIBIT 99 TRANSPORT MEDIA MARKET IN GERMANY 2022-2028 ($ MILLION)
- EXHIBIT 100 SPAIN: COVID-19 DAILY CASES (2022)
- EXHIBIT 101 TRANSPORT MEDIA MARKET IN SPAIN 2022-2028 ($ MILLION)
- EXHIBIT 102 APAC TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 103 APAC TRANSPORT MEDIA MARKET: KEY COUNTRIES
- EXHIBIT 104 TRANSPORT MEDIA MARKET IN APAC 2022-2028 ($ MILLION)
- EXHIBIT 105 INCREMENTAL GROWTH IN APAC 2022 & 2028
- EXHIBIT 106 TRANSPORT MEDIA MARKET IN CHINA 2022-2028 ($ MILLION)
- EXHIBIT 107 JAPAN: THE PREVALENCE FOR PCR POSITIVITY (2022)
- EXHIBIT 108 TRANSPORT MEDIA MARKET IN JAPAN 2022-2028 ($ MILLION)
- EXHIBIT 109 TRANSPORT MEDIA MARKET IN INDIA 2022-2028 ($ MILLION)
- EXHIBIT 110 TRANSPORT MEDIA MARKET IN AUSTRALIA 2022-2028 ($ MILLION)
- EXHIBIT 111 TRANSPORT MEDIA MARKET IN SOUTH KOREA 2022-2028 ($ MILLION)
- EXHIBIT 112 LATIN AMERICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
- EXHIBIT 113 LATIN AMERICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 114 TRANSPORT MEDIA MARKET IN LATIN AMERICA 2022-2028 ($ MILLION)
- EXHIBIT 115 INCREMENTAL GROWTH IN LATIN AMERICA 2022 & 2028
- EXHIBIT 116 BRAZIL: GEOGRAPHIC DISTRIBUTION OF THERAPEUTIC DIAGNOSTIC SUPPORT SERVICES & TYPE OF PROVIDER
- EXHIBIT 117 TRANSPORT MEDIA MARKET IN BRAZIL 2022-2028 ($ MILLION)
- EXHIBIT 118 TRANSPORT MEDIA MARKET IN MEXICO 2022-2028 ($ MILLION)
- EXHIBIT 119 TRANSPORT MEDIA MARKET IN ARGENTINA2022-2028 ($ MILLION)
- EXHIBIT 120 HIGH ANNUAL INCIDENCE RATE OF RSV (2021)
- EXHIBIT 121 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET: INCREMENTAL GROWTH & ABSOLUTE GROWTH
- EXHIBIT 122 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET: KEY COUNTRIES
- EXHIBIT 123 TRANSPORT MEDIA MARKET IN MIDDLE EAST & AFRICA 2022-2028 ($ MILLION)
- EXHIBIT 124 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2022 & 2028
- EXHIBIT 125 TRANSPORT MEDIA MARKET IN TURKEY 2022-2028 ($ MILLION)
- EXHIBIT 126 TRANSPORT MEDIA MARKET IN SAUDI ARABIA 2022-2028 ($ MILLION)
- EXHIBIT 127 TRANSPORT MEDIA MARKET IN SOUTH AFRICA 2022-2028 ($ MILLION)
- EXHIBIT 128 PURE & DIVERSIFIED VENDORS IN TRANSPORT MEDIA MARKET
- EXHIBIT 129 VENDORS OFFERING TRANSPORT MEDIA: CAPABILITIES & EXPERTISE ASSESSMENT
- EXHIBIT 130 VENDORS OFFERING TRANSPORT MEDIA: MARKET DOMINANCE ANALYSIS (2022)
LIST OF TABLES
- TABLE 1 KEY CAVEATS
- TABLE 2 CURRENCY CONVERSION 2015-2022
- TABLE 3 NEWLY LAUNCHED TRANSPORT MEDIUM SOLUTIONS
- TABLE 4 PRIMESTORE MTM EFFECTIVENESS
- TABLE 5 VIRAL TRANSPORT MEDIUM AVAILABILITY IN TWO FORMATS
- TABLE 6 MONKEYPOX CASES STATISTICS 2022 (MAJOR IMPACTING COUNTRIES) IN NOVEMBER FIRST WEEK
- TABLE 7 VIRAL TRANSPORT MEDIA FOR MONKEYPOX SPECIMEN COLLECTION
- TABLE 8 SWAB VALIDATION USING IN-HOUSE VTM
- TABLE 9 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 10 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 11 UNIVERSAL TRANSPORT MEDIA FOR MONKEYPOX SPECIMEN COLLECTION
- TABLE 12 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 13 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 14 LIST OF FEW MOLECULAR TRANSPORT MEDIA PRODUCTS
- TABLE 15 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 16 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 17 OTHERS TRANSPORT MEDIA WITH MANUFACTURERS AND TYPE
- TABLE 18 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 19 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 20 GLOBAL COVID-19 TEST DONE FOR DIAGNOSIS FROM 2019 TO 2022 (NOVEMBER 2022)
- TABLE 21 DIAGNOSIS SEGMENT TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 22 DIAGNOSIS SEGMENT TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 23 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 24 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 25 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 26 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 27 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 28 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 29 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 30 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 31 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 32 HOSPITALS AND CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 33 OTHER END-USER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 34 OTHER END-USER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 35 MONKEYPOX REPORTING CASES 2022
- TABLE 36 NORTH AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 37 NORTH AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 38 NORTH AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 39 NORTH AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 40 NORTH AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 41 NORTH AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 42 NORTH AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 ($ MILLION)
- TABLE 43 NORTH AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 (%)
- TABLE 44 MAJOR MARKET PLAYERS OPERATING IN US
- TABLE 45 CANADA SWAB & VIRAL TRANSPORT MEDIUM SET IMPORT STATISTICS 2019 (PRODUCT CODE 382100 & QUANTITY UNIT KG)
- TABLE 46 EUROPE TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 47 EUROPE TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 48 EUROPE TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 49 EUROPE TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 50 EUROPE TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 51 EUROPE TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 52 EUROPE TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 ($ MILLION)
- TABLE 53 EUROPE TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 (%)
- TABLE 54 APAC TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 55 APAC TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 56 APAC TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 57 APAC TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 58 APAC TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 59 APAC TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 60 APAC TRANSPORT MEDIA MARKET BY END-USER 2022-2028 ($ MILLION)
- TABLE 61 APAC TRANSPORT MEDIA MARKET BY END-USER 2022-2028 (%)
- TABLE 62 LATIN AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 63 LATIN AMERICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 64 LATIN AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 65 LATIN AMERICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 66 LATIN AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 67 LATIN AMERICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 68 LATIN AMERICA TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 ($ MILLION)
- TABLE 69 LATIN AMERICA TRANSPORT MEDIA MARKET BY END-USER 2022-2028 (%)
- TABLE 70 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 71 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 72 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 73 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 74 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 75 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 76 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY END-USER 2022-2028 ($ MILLION)
- TABLE 77 MIDDLE EAST & AFRICA TRANSPORT MEDIA MARKET BY END-USER 2022-2028 (%)
- TABLE 78 BD: MAJOR PRODUCT OFFERINGS
- TABLE 79 HARDY DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
- TABLE 80 HIMEDIA LABORATORIES: MAJOR PRODUCT OFFERINGS
- TABLE 81 LABORATORY CORPORATION OF AMERICA: MAJOR PRODUCT OFFERINGS
- TABLE 82 PURITAN MEDICA PRODUCTS: MAJOR PRODUCT OFFERINGS
- TABLE 83 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
- TABLE 84 VIRCELL: MAJOR PRODUCT OFFERINGS
- TABLE 85 AB MEDICAL: MAJOR PRODUCT OFFERINGS
- TABLE 86 ALPHA-TEC SYSTEMS: MAJOR PRODUCT OFFERINGS
- TABLE 87 ACCUGENE USA: MAJOR PRODUCT OFFERINGS
- TABLE 88 APICAL SCIENTIFIC: MAJOR PRODUCT OFFERINGS
- TABLE 89 AZOOKA LABS: MAJOR PRODUCT OFFERINGS
- TABLE 90 BIOMED DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
- TABLE 91 BIOBOAVISTA: MAJOR PRODUCT OFFERINGS
- TABLE 92 BIOGENEX: MAJOR PRODUCT OFFERINGS
- TABLE 93 BIOLOGIX GROUP: MAJOR PRODUCT OFFERINGS
- TABLE 94 BIOCOMMA: MAJOR PRODUCT OFFERINGS
- TABLE 95 CHARM SCIENCES: MAJOR PRODUCT OFFERINGS
- TABLE 96 CREATIVE LIFE SCIENCES.: MAJOR PRODUCT OFFERINGS
- TABLE 97 CITOTEST LABWARE MANUFACTURING: MAJOR PRODUCT OFFERINGS
- TABLE 98 CPT MEDICAL: MAJOR PRODUCT OFFERINGS
- TABLE 99 COPAN DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
- TABLE 100 DIASORIN MOLECULAR: MAJOR PRODUCT OFFERINGS
- TABLE 101 EKF DIAGNOSTICS HOLDING: MAJOR PRODUCT OFFERINGS
- TABLE 102 ENSOL BIOSCIENCES: MAJOR PRODUCT OFFERINGS
- TABLE 103 GENERAL BIOLOGICS: MAJOR PRODUCT OFFERINGS
- TABLE 104 GENTUERI: MAJOR PRODUCT OFFERINGS
- TABLE 105 HAN CHANG MEDIC: MAJOR PRODUCT OFFERINGS
- TABLE 106 HEBEI CHAORAN MEDICAL INSTRUMENTS: MAJOR PRODUCT OFFERINGS
- TABLE 107 INNOLYZER LABS: MAJOR PRODUCT OFFERINGS
- TABLE 108 KSL DIAGNOSTICS: MAJOR PRODUCT OFFERINGS
- TABLE 109 LUCENCE HEALTH: MAJOR PRODUCT OFFERINGS
- TABLE 110 LAUNCHWORKS: MAJOR PRODUCT OFFERINGS
- TABLE 111 LIOFILCHEM: MAJOR PRODUCT OFFERINGS
- TABLE 112 MEDICAL WIRE & EQUIPMENT: MAJOR PRODUCT OFFERINGS
- TABLE 113 MIRACLEAN TECHNOLOGY: MAJOR PRODUCT OFFERINGS
- TABLE 114 METADESIGN SOLUTIONS: MAJOR PRODUCT OFFERINGS
- TABLE 115 QUIDEL CORPORATION: MAJOR PRODUCT OFFERINGS
- TABLE 116 TRINITY BIOTECH: MAJOR PRODUCT OFFERINGS
- TABLE 117 MANILA HEALTHTEK: MAJOR PRODUCT OFFERINGS
- TABLE 118 MATTEK: MAJOR PRODUCT OFFERINGS
- TABLE 119 NODFORD INTERNATIONAL: MAJOR PRODUCT OFFERINGS
- TABLE 120 STARPLEX SCIENTIFIC: MAJOR PRODUCT OFFERINGS
- TABLE 121 SANSURE BIOTECH: MAJOR PRODUCT OFFERINGS
- TABLE 122 SISCO RESEARCH LABORATORIES: MAJOR PRODUCT OFFERINGS
- TABLE 123 TEKNOVA: MAJOR PRODUCT OFFERINGS
- TABLE 124 TITAN BIOTECH: MAJOR PRODUCT OFFERINGS
- TABLE 125 VEGAS BIOTECH: MAJOR PRODUCT OFFERINGS
- TABLE 126 YOCON BIOLOGY TECHNOLOGY COMPANY: MAJOR PRODUCT OFFERINGS
- TABLE 127 ZYBIO: MAJOR PRODUCT OFFERINGS
- TABLE 128 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 129 GLOBAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 130 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 ($ MILLION)
- TABLE 131 GLOBAL TRANSPORT MEDIA MARKET BY PRODUCT 2022-2028 (%)
- TABLE 132 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 ($ MILLION)
- TABLE 133 GLOBAL TRANSPORT MEDIA MARKET BY APPLICATION 2022-2028 (%)
- TABLE 134 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 ($ MILLION)
- TABLE 135 GLOBAL TRANSPORT MEDIA MARKET BY INDICATION 2022-2028 (%)
- TABLE 136 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 ($ MILLION)
- TABLE 137 GLOBAL TRANSPORT MEDIA MARKET BY END-USERS 2022-2028 (%)
- TABLE 138 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 139 VIRAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 140 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 141 UNIVERSAL TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 142 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 143 MOLECULAR TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 144 OTHER TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 145 OTHERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 146 DIAGNOSIS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 147 DIAGNOSIS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 148 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 149 PRE-CLINICAL TESTING TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 150 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 151 VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 152 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 153 NON-VIRAL DISEASE TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 154 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 155 DIAGNOSTIC LABS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 156 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 157 HOSPITALS & CLINICS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
- TABLE 158 OTHER END-USERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 ($ MILLION)
- TABLE 159 OTHER END-USERS TRANSPORT MEDIA MARKET BY GEOGRAPHY 2022-2028 (%)
